{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:32:01Z","timestamp":1792672321818,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.jns.2009.08.014","type":"journal-article","created":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T08:17:20Z","timestamp":1252484240000},"page":"12-17","source":"Crossref","is-referenced-by-count":281,"title":["Epidemiology of psychosis in Parkinson's disease"],"prefix":"10.1016","volume":"289","author":[{"given":"Gilles","family":"F\u00e9nelon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2009.08.014_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"issue":"suppl4","key":"10.1016\/j.jns.2009.08.014_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1017\/S1092852900017284","article-title":"Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms","volume":"13","author":"F\u00e9nelon","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jns.2009.08.014_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00415-004-0483-3","article-title":"Psychiatric aspects of Parkinson's disease \u2014 an update","volume":"251","author":"Schrag","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.2005.083113","article-title":"Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress","volume":"78","author":"Aarsland","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2009.08.014_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00002826-199108000-00001","article-title":"The management of levodopa psychoses","volume":"14","author":"Friedman","year":"1991","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jns.2009.08.014_bib6","series-title":"Mental dysfunction in Parkinson's disease","article-title":"Psychosis in basal ganglia disorders","author":"Cummings","year":"1993"},{"key":"10.1016\/j.jns.2009.08.014_bib7","first-page":"115","article-title":"Parkinson's disease: drug-induced psychiatric states","volume":"65","author":"Factor","year":"1995","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/mds.21382","article-title":"Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS\/NIMH Work Group","volume":"22","author":"Ravina","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jns.2009.08.014_bib10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/jnnp.70.6.734","article-title":"Prospective study of hallucinations and delusions in Parkinson's disease","volume":"70","author":"Holroyd","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2009.08.014_bib11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/01.wnl.0000215428.46057.3d","article-title":"Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review)","volume":"66","author":"Miyazaki","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mds.21875","article-title":"Scales to assess psychosis in Parkinson's disease: critique and recommendations","volume":"23","author":"Fernandez","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2007.01.017","article-title":"Correlates of hallucinations in schizophrenia: a cross-cultural evaluation","volume":"92","author":"Thomas","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jns.2009.08.014_bib14","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archneur.1996.00550120077019","article-title":"Visual hallucinations associated with Parkinson's disease","volume":"53","author":"Sanchez-Ramos","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jnnp.63.4.434","article-title":"Hallucinosis in idiopathic Parkinson's disease","volume":"63","author":"Graham","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2009.08.014_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/jnnp.64.4.533","article-title":"Auditory hallucinations in Parkinson's disease","volume":"64","author":"Inzelberg","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2009.08.014_bib17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1212\/01.WNL.0000161872.85903.8E","article-title":"Association between family history of dementia and hallucinations in Parkinson disease","volume":"64","author":"Paleacu","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib18","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/mds.20582","article-title":"Relationship between hallucinations, delusions and REM behavior disorder in Parkinson's disease","volume":"20","author":"Pacchetti","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jnnp.2007.124677","article-title":"Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism","volume":"79","author":"Williams","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2009.08.014_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2377-8-21","article-title":"A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease","volume":"8","author":"Papapetropoulos","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00702-004-0209-9","article-title":"Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease","volume":"111","author":"Merims","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2009.08.014_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/01.WNL.0000129843.15756.A3","article-title":"Psychiatric comorbidities in patients with Parkinson disease and psychosis","volume":"63","author":"Marsh","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archneur.56.5.595","article-title":"Prevalence and clinical correlates of psychotic symptoms in Parkinson disease. A community-based study","volume":"56","author":"Aarsland","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s004150200032","article-title":"How common are complications of Parkinson's disease","volume":"249","author":"Schrag","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.wnf.0000180228.77802.32","article-title":"Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments","volume":"28","author":"Chou","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jns.2009.08.014_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1212\/01.WNL.0000148479.10865.FE","article-title":"Hallucinations and sleep disorders in PD. Six-year prospective longitudinal study","volume":"64","author":"Goetz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/mds.21429","article-title":"Rate of progression in Parkinson's disease. A prospective study","volume":"22","author":"Schrag","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20\u00a0years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1212\/01.wnl.0000265593.34438.00","article-title":"Risk factors for somnolence, edema, and hallucinations in early Parkinson disease","volume":"69","author":"Biglan","year":"2007","journal-title":"Neurology"},{"issue":"suppl1","key":"10.1016\/j.jns.2009.08.014_bib30","first-page":"S288","article-title":"Development of psychosis in Parkinson's disease \u2014 a 12\u00a0year follow-up study","volume":"23","author":"Forsaa","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","article-title":"Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study","volume":"4","author":"Williams","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000191325.31068.c4","article-title":"Hallucinations in the prelevodopa era in Parkinson's disease","volume":"66","author":"F\u00e9nelon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/01.WNL.0000103444.45882.D8","article-title":"Ophthalmologic features of Parkinson's disease","volume":"62","author":"Biousse","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib34","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/jnnp.2008.166959","article-title":"The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease","volume":"80","author":"Aarsland","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2009.08.014_bib35","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson's disease","volume":"351","author":"Parkinson Study Group","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jns.2009.08.014_bib36","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1212\/WNL.49.3.724","article-title":"Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group","volume":"49","author":"Shannon","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib37","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/jama.218.13.1915","article-title":"Psychiatric side-effects of levodopa in man","volume":"218","author":"Goodwin","year":"1971","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jns.2009.08.014_bib38","first-page":"CD006564","article-title":"Dopamine agonist therapy in early Parkinson's disease (review)","author":"Stowe","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jns.2009.08.014_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.parkreldis.2008.07.004","article-title":"Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis","volume":"15","author":"Baker","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00415-005-0840-x","article-title":"Factors associated with drug-induced visual hallucinations in Parkinson's disease","volume":"252","author":"Papapetropoulos","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jns.2006.05.025","article-title":"Visual hallucinations in Parkinson's disease: clues to separate origins","volume":"248","author":"Onofrj","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2009.08.014_bib42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.parkreldis.2006.03.006","article-title":"Frequency and correlates of co-morbid depression in Parkinson's disease","volume":"12","author":"Weintraub","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s004150050104","article-title":"A study of hallucinations in patients with Parkinson's disease","volume":"244","author":"Klein","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib44","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/gps.389","article-title":"A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia","volume":"16","author":"Aarsland","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jns.2009.08.014_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-0404.2007.00860.x","article-title":"Clinical evaluation of Parkinson's disease dementia: association with ageing and visual hallucinations","volume":"116","author":"Kitayama","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2009.08.014_bib46","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/jnnp.65.4.610","article-title":"A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis","volume":"64","author":"Shergill","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2009.08.014_bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/jnnp.70.6.727","article-title":"Visual hallucinations in Parkinson's disease: a review and phenomenological survey","volume":"70","author":"Barnes","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2009.08.014_bib48","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.51.3.811","article-title":"Early dopaminergic hallucinations in parkinsonian patients","volume":"51","author":"Goetz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002826-198205020-00003","article-title":"Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis","volume":"5","author":"Nausieda","year":"1982","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jns.2009.08.014_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0","article-title":"Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease","volume":"14","author":"Pappert","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0891988705284739","article-title":"Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease","volume":"19","author":"Matsui","year":"2006","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib52","first-page":"289","article-title":"Poor visual discrimination and visual hallucinations in Parkinson's disease","volume":"21","author":"Diederich","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jns.2009.08.014_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s007020050005","article-title":"Risk factors for dementia, depression, and psychosis in long-standing Parkinson's disease","volume":"107","author":"Giladi","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2009.08.014_bib54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00008571-200002000-00006","article-title":"Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease","volume":"10","author":"Makoff","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jns.2009.08.014_bib55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archneur.58.2.209","article-title":"Genetic variation analysis in Parkinson disease patients with and without hallucinations: case-control study","volume":"58","author":"Goetz","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2003.11.006","article-title":"Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease","volume":"355","author":"Wang","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2009.08.014_bib57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00008571-200306000-00008","article-title":"Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease","volume":"13","author":"Wang","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jns.2009.08.014_bib58","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archneur.61.8.1280","article-title":"Genetic polymorphisms in Parkinson disease subjects with and without hallucinations","volume":"61","author":"Goldman","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib59","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neulet.2007.06.028","article-title":"Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes","volume":"422","author":"Kiferle","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2009.08.014_bib60","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.10409","article-title":"HLA typing does not predict REM Sleep behaviour disorder and hallucinations in Parkinson's disease","volume":"18","author":"Onofrj","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib61","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1212\/WNL.57.11.2078","article-title":"Prospective longitudinal assessment of hallucinations in Parkinson's disease","volume":"57","author":"Goetz","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mds.20263","article-title":"Hallucinations in Parkinson's disease: a follow-up study","volume":"20","author":"Do\u00e9 de Maindreville","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib63","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archneur.63.5.713","article-title":"The malignant course of \u201cbenign hallucinations\u201d in Parkinson's disease","volume":"63","author":"Goetz","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.08.014_bib64","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/mds.22132","article-title":"Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: positive impact on long-term worsening","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib65","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1212\/WNL.43.11.2227","article-title":"Risk factors for nursing home placement in advanced Parkinson's disease","volume":"43","author":"Goetz","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib66","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/01.WNL.0000068010.82167.CF","article-title":"Longitudinal outcome of Parkinson's disease patients with psychosis","volume":"60","author":"Factor","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib67","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1532-5415.2000.tb06891.x","article-title":"Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study","volume":"48","author":"Aarsland","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jns.2009.08.014_bib68","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mds.20216","article-title":"Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom","volume":"19","author":"Hobson","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2009.08.014_bib69","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/01.wnl.0000242630.52203.8f","article-title":"Clinical phenotype of Parkinson disease dementia","volume":"67","author":"Galvin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib70","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.45.4.669","article-title":"Mortality and hallucinations in nursing home patients with advanced Parkinson's disease","volume":"45","author":"Goetz","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.08.014_bib71","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1212\/01.WNL.0000036610.36834.E0","article-title":"The association of incident dementia with mortality in PD","volume":"59","author":"Levy","year":"2002","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09007679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09007679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T03:50:43Z","timestamp":1545018643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X09007679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":71,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0022510X09007679"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2009.08.014","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}